Drug intelligence / Profile preview

Lipase Thera-blend + tributyrin

Development stage
Unknown
Lead developer
Enzymedica
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Lipase Thera-blend + tributyrin is a combination product containing **lipase enzymes** (derived from Candida rugosa and Rhizopus oryzae) and **tributyrin**, a triglyceride prodrug of butyric acid (butyrate)[2]. Lipase Thera-blend provides enzyme replacement to aid the digestion of fats, while tributyrin serves as a source of butyrate, a short-chain fatty acid linked to gut and metabolic health[2][4]. Tributyrin must be hydrolyzed by lipase to release butyrate, making the combination relevant for efficient delivery and absorption of butyrate. The primary indications involve supporting memory and cognitive function in adults with self-reported memory problems, and potentially aiding in digestive health[2].

Brand names
Lipase Thera-blend + tributyrin
Other names
Lipase Thera-blend + tributyrin

Beyond the preview

Go deeper on Lipase Thera-blend + tributyrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipase Thera-blend + tributyrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call